Connection

Scott Weaver to Vaccines, Synthetic

Back to Details
This is a "connection" page, showing publications Scott Weaver has written about Vaccines, Synthetic.
Scott Weaver
Connection Strength
0.235
Vaccines, Synthetic
  1. Biotechnological Applications of an Insect-Specific Alphavirus. DNA Cell Biol. 2017 Dec; 36(12):1045-1049.
    View in: PubMed
    Score: 0.070
  2. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge. J Virol. 2017 04 15; 91(8).
    View in: PubMed
    Score: 0.067
  3. Experimental infection of Aedes sollicitans and Aedes taeniorhynchus with two chimeric Sindbis/Eastern equine encephalitis virus vaccine candidates. Am J Trop Med Hyg. 2008 Jan; 78(1):93-7.
    View in: PubMed
    Score: 0.035
  4. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants. Nature. 2021 08; 596(7871):273-275.
    View in: PubMed
    Score: 0.022
  5. Neutralizing Activity of BNT162b2-Elicited Serum. N Engl J Med. 2021 04 15; 384(15):1466-1468.
    View in: PubMed
    Score: 0.022
  6. A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections. Vaccine. 2018 06 22; 36(27):3894-3900.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.